Skip to main content
Livermore
Livermore
ZHEN

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

CLSD holding history

Clearside Biomedical, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CLSD overviewAll 13F holders of CLSDFull Q4 2025 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of CLSD by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−221,968−100.0%Sold outHolders
Q3 2025221,968$881.2K<0.1%−2,236−1.0%ReducedConverted for a 1-for-15 splitHolders
Q2 20253,363,061$2.69M<0.1%+556,454+19.8%AddedHolders
Q1 20252,806,607$2.58M<0.1%00.0%UnchangedHolders
Q4 20242,806,607$2.67M<0.1%−33,371−1.2%ReducedHolders
Q3 20242,839,978$3.61M<0.1%00.0%UnchangedHolders
Q2 20242,839,978$3.69M<0.1%+349,182+14.0%AddedHolders
Q1 20242,490,796$3.81M<0.1%+314,480+14.5%AddedHolders
Q4 20232,176,316$2.55M<0.1%+9,431+0.4%AddedHolders
Q3 20232,166,885$1.88M<0.1%00.0%UnchangedHolders
Q2 20232,166,885$2.43M<0.1%00.0%UnchangedHolders
Q1 20232,166,885$2.25M<0.1%00.0%UnchangedHolders
Q4 20222,166,885$2.43M<0.1%+1,208+0.1%AddedHolders
Q3 20222,165,677$2.45M<0.1%00.0%UnchangedHolders
Q2 20222,165,677$3.18M<0.1%00.0%UnchangedHolders
Q1 20222,165,677$4.96M<0.1%−9,475−0.4%ReducedHolders
Q4 20212,175,152$5.98M<0.1%−3,020−0.1%ReducedHolders
Q3 20212,178,172$13.1M<0.1%+72,082+3.4%AddedHolders
Q2 20212,106,090$10.3M<0.1%+378,559+21.9%AddedHolders
Q1 20211,727,531$4.27M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.